ALORA Fundamental Analysis - ALTHEORA SA

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ALORA. ALORA was compared to 60 industry peers in the Electrical Equipment industry. ALORA may be in some trouble as it scores bad on both profitability and health. ALORA does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALORA has reported negative net income.

ALORA had a positive operating cash flow in the past year.

In the past 5 years ALORA always reported negative net income.

In multiple years ALORA reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -5.28%, ALORA is not doing good in the industry: 65.00% of the companies in the same industry are doing better.

Looking at the Return On Equity, with a value of -16.98%, ALORA is doing worse than 68.33% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-5.28%
ROE	-16.98%
ROIC	N/A

ROA(3y)-4.78%

ROA(5y)-3.19%

ROE(3y)-15.18%

ROE(5y)-10.24%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 60.11%, ALORA belongs to the top of the industry, outperforming 88.33% of the companies in the same industry.

In the last couple of years the Gross Margin of ALORA has grown nicely.

ALORA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	60.11%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.44%

GM growth 5Y15.59%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALORA does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ALORA remains at a similar level compared to 1 year ago.

ALORA has more shares outstanding than it did 5 years ago.

The debt/assets ratio for ALORA is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.86, we must say that ALORA is in the distress zone and has some risk of bankruptcy.

ALORA has a worse Altman-Z score (0.86) than 73.33% of its industry peers.

A Debt/Equity ratio of 0.96 indicates that ALORA is somewhat dependend on debt financing.

ALORA has a Debt to Equity ratio of 0.96. This is amonst the worse of the industry: ALORA underperforms 80.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.96
Debt/FCF	N/A
Altman-Z	0.86

ROIC/WACCN/A

WACC6.94%

2.3 Liquidity

A Current Ratio of 1.05 indicates that ALORA should not have too much problems paying its short term obligations.

With a Current ratio value of 1.05, ALORA is not doing good in the industry: 76.67% of the companies in the same industry are doing better.

ALORA has a Quick Ratio of 1.05. This is a bad value and indicates that ALORA is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Quick ratio value of 0.56, ALORA is not doing good in the industry: 93.33% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	1.05
Quick Ratio	0.56

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALORA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.91%, which is quite impressive.

Looking at the last year, ALORA shows a very negative growth in Revenue. The Revenue has decreased by -10.51% in the last year.

ALORA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.05% yearly.

EPS 1Y (TTM)50.91%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%62.84%

Revenue 1Y (TTM)-10.51%

Revenue growth 3Y4.98%

Revenue growth 5Y5.05%

Sales Q2Q%-14.45%

3.2 Future

ALORA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.42% yearly.

ALORA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.00% yearly.

EPS Next Y100%

EPS Next 2Y41.42%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year5.13%

Revenue Next 2Y5%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALORA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ALORA's earnings are expected to grow with 41.42% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y41.42%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALORA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ALTHEORA SA

EPA:ALORA (8/6/2025, 7:00:00 PM)

0.438

+0.05 (+14.06%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryElectrical Equipment

Earnings (Last)04-17 2025-04-17/amc

Earnings (Next)09-16 2025-09-16

Inst Owners5.56%

Inst Owner ChangeN/A

Ins Owners2.17%

Ins Owner ChangeN/A

Market Cap5.93M

Analysts86.67

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.16
P/FCF	N/A
P/OCF	6.67
P/B	0.58
P/tB	0.73
EV/EBITDA	N/A

EPS(TTM)-0.13

EYN/A

EPS(NY)0

Fwd EYN/A

FCF(TTM)-0.02

FCFYN/A

OCF(TTM)0.07

OCFY14.98%

SpS2.73

BVpS0.76

TBVpS0.6

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-5.28%
ROE	-16.98%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	60.11%
FCFM	N/A

ROA(3y)-4.78%

ROA(5y)-3.19%

ROE(3y)-15.18%

ROE(5y)-10.24%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.44%

GM growth 5Y15.59%

F-Score6

Asset Turnover1.12

Health

		Industry Rank	Sector Rank
Debt/Equity	0.96
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	3.08%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.05
Quick Ratio	0.56
Altman-Z	0.86

F-Score6

WACC6.94%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)4.76%

Cap/Sales(5y)6.86%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)50.91%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%62.84%

EPS Next Y100%

EPS Next 2Y41.42%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-10.51%

Revenue growth 3Y4.98%

Revenue growth 5Y5.05%

Sales Q2Q%-14.45%

Revenue Next Year5.13%

Revenue Next 2Y5%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y3.75%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year468.93%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-394.19%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-29.86%

OCF growth 3Y0.92%

OCF growth 5Y-24.26%

ALTHEORA SA (ALORA.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens